Placental Immunopathology in the FIV-infected Cat Model

描述（由申请人提供）：宫内传播是儿科HIV感染的重要来源，HIV感染妇女流产率较高。病毒经胎盘传播或干扰妊娠的机制尚不清楚。胎盘免疫调节剂参与正常妊娠的调节。成功的妊娠通常偏向于Th2介导的免疫应答，而Th1细胞因子的表达必须受到抑制。滋养层细胞和蜕膜白细胞表达调节胎盘免疫学的免疫调节剂。滋养层细胞可以感染艾滋病毒。胎盘中表达的一些免疫调节剂增强了HIV的表达，HIV感染可以改变滋养层细胞因子的特征。因此，胎盘免疫失调可能发生在HIV感染期间，可能有助于HIV垂直转移和流产。感染FIV的猫服务是HIV垂直感染的模型，垂直感染导致妊娠受损。初步数据表明，FIV感染的皇后胎盘Th1细胞因子的表达增加。本项目的目的是评估胎盘免疫病理学在细胞水平上，在早期和晚期妊娠，开始了解机制如何慢病毒经胎盘传播发生和危害妊娠。本研究的具体目的是：1）确定FIV感染是否诱导滋养层细胞的免疫病理学。胎盘滋养层细胞中代表性Th1和Th2细胞因子、趋化因子受体CXCR 4（FIV的受体）、其配体SDF和FIV的表达将使用激光捕获显微切割（LCM）捕获滋养层细胞，然后通过TaqMan真实的时间PCR来评估基因的表达。2)确定FIV感染是否诱导胎盘细胞毒性。将使用免疫组织化学定量蜕膜白细胞群，并在LCM和真实的时间PCR后测定这些细胞中的细胞因子谱。病毒感染对滋养层细胞凋亡的影响将使用TUNEL测定来检查。总的来说，从这项研究中获得的数据可以确定胎盘免疫因素，导致FIV经胎盘传播和妊娠受损。该项目的长期目标是为基于免疫的干预策略提供知识基础，以最大限度地减少慢病毒诱导的胎盘免疫病理学和胎儿损伤。使用FIV感染的猫模型经胎盘HIV感染，我们将在细胞水平上评估胎盘免疫学。将在感染和未感染的妊娠猫中检查免疫调节剂的产生。我们希望确定促进子宫内病毒传播和胎儿损伤的免疫参数。

DESCRIPTION (provided by applicant): Transmission in utero is an important source of pediatric HIV infections, and miscarriages occur at an elevated rate in HIV-infected women. The mechanism for transplacental transmission or perturbation of pregnancy by the virus is unknown. Placental immunomodulators are involved in the regulation of normal pregnancy. Successful pregnancy typically is biased toward a Th2-mediated immune response, and Th1 cytokine expression must by suppressed. Trophoblastic cells and decidual leukocytes express immunomodulators that regulate placental immunology. Trophoblasts can be infected with HIV. HIV expression is augmented by some immunomodulators that are expressed in the placenta, and HIV infections can alter the profile of trophoblastic cytokines. Thus, dysregulation of placental immunology probably occurs during HIV infections, possibly contributing to HIV vertical transfer and miscarriage. The FIV-infected cat serves is a model for HIV vertical infections, with vertical infection resulting in compromised pregnancy. Preliminary data indicate increased expression of placental Th1 cytokines in FIV-infected queens. The purpose of this project is to evaluate placental immunopathology at the cellular level, at early and late gestation, to begin to understand mechanistically how lentiviral transplacental transmission occurs and compromises pregnancy. The specific aims of this project are to: 1) Determine whether FIV infection induces immunopathology in trophoblasts. The expression of representative Th1 and Th2 cytokines, the chemokine receptor CXCR4 (a receptor for FIV), its ligand SDF, and FIV in placental trophoblasts will be determined using laser capture microdissection (LCM) to capture trophoblasts, followed by TaqMan real time PCR to assess expression of the genes. 2) Determine whether FIV infection induces placental cytotoxicity. Decidual leukocyte populations will be quantified using immunohistochemistry, and cytokine profiles in these cells will be determined, following LCM and real time PCR. The effect of viral infection on apoptosis of trophoblasts will be examined using the TUNEL assay. Collectively, the data obtained from this study may identify placental immunological factors that result in FIV transplacental transmission and compromised pregnancy. The long-term goal of this project is to provide the intellectual basis for immune-based intervention strategies to minimize lentivirus-induced placental immunopathology and fetal damage. Using the FIV-infected cat to model transplacental HIV infection, we will evaluate placental immunology at the cellular level. The production of immunomodulators will be examined in infected and uninfected pregnant cats. We hope to identify immune parameters promoting in utero viral transmission and fetal damage.